©The Author(s) 2023.
World J Gastrointest Oncol. Aug 15, 2023; 15(8): 1332-1341
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1332
Published online Aug 15, 2023. doi: 10.4251/wjgo.v15.i8.1332
Table 4 Hormone status and immunohistochemistry markers for patients with metastatic breast cancer to upper gastrointestinal tract
| Esophagus (%) | Stomach (%) | |
| Tumor receptors of primary breast tumor | ||
| ER+ | 4 (67) | 37 (88) |
| ER- | 3 (50) | 5 (12) |
| PRG+ | 2 (33) | 29 (69) |
| PRG- | 4 (67) | 12 (29) |
| HER+ | 0 (0) | 2 (5) |
| HER- | 3 (50) | 23 (55) |
| Tumor receptors and markers of gastrointestinal metastases | ||
| ER+ | 13 (100) | 86 (57) |
| ER- | - | 39 (26) |
| PRG+ | 9 (69) | 30 (20) |
| PRG- | - | 18 (12) |
| HER+ | 1 (8) | 8 (5) |
| HER- | 1 (8) | 38 (25) |
| CK7+ | 3 (23) | 25 (17) |
| CK20+ | - | 1 (1) |
| CK20- | 3 (23) | 18 (12) |
- Citation: Da Cunha T, Restrepo D, Abi-Saleh S, Dharan M. Breast cancer metastasizing to the upper gastrointestinal tract (the esophagus and the stomach): A comprehensive review of the literature. World J Gastrointest Oncol 2023; 15(8): 1332-1341
- URL: https://www.wjgnet.com/1948-5204/full/v15/i8/1332.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i8.1332